We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$182M
1-Year Est. Return
18.52%
This Fund
S&P 500
This Quarter
Est. Return
+8.75%
1 Year Est. Return
+18.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$181M
AUM Growth
+$87.9M
(+94%)
Cap. Flow
+$79.7M
Cap. Flow
% of AUM
43.92%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
577
New
288
Increased
108
Reduced
61
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$4.19M |
| 2 |
K
Kellanova
K
|
+$3.22M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$2.29M |
| 4 |
Progressive
PGR
|
+$2.17M |
| 5 |
Republic Services
RSG
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FYBR
Frontier Communications
FYBR
|
+$1.86M |
| 2 |
Hilton Worldwide
HLT
|
+$1.58M |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.18M |
| 4 |
Walt Disney
DIS
|
+$1.15M |
| 5 |
PNC Financial Services
PNC
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.51% |
| 2 | Financials | 17.83% |
| 3 | Healthcare | 13.23% |
| 4 | Industrials | 13.09% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
426
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $28.4K | 0.02% |
+52,459
| New | +$31.1K |
|
|
LPRO
427
Open Lending Corp
LPRO
$372M
| $28K | 0.02% |
+14,432
| New | +$23.3K |
|
428
Lexicon Pharmaceuticals
LXRX
$1.06B
| $28K | 0.02% |
+29,559
| New | +$19.2K |
|
429
Ironwood Pharmaceuticals
IRWD
$635M
| $27.8K | 0.02% |
38,765
+28,735
| +286% | +$22.6K |
|
430
BRC Inc
BRCC
$133M
| $27.6K | 0.02% |
+21,064
| New | +$39K |
|
|
NOTE
431
DELISTED
FiscalNote
NOTE
| $26.6K | 0.01% |
+4,133
| New | +$31K |
|
432
Heron Therapeutics
HRTX
$89.1M
| $26.2K | 0.01% |
+12,648
| New | +$25.8K |
|
433
Black Diamond Therapeutics
BDTX
$103M
| $25.1K | 0.01% |
+10,139
| New | +$19.5K |
|
|
OLPX
434
DELISTED
Olaplex Holdings
OLPX
| $25.1K | 0.01% |
+17,897
| New | +$23.3K |
|
435
Fractyl Health
GUTS
$129M
| $24.1K | 0.01% |
+14,900
| New | +$24.1K |
|
436
Precigen
PGEN
$1.76B
| $23.4K | 0.01% |
+16,470
| New | +$23.4K |
|
437
Clean Energy Fuels
CLNE
$524M
| $23.2K | 0.01% |
+11,904
| New | +$20.2K |
|
438
Companhia Siderúrgica Nacional
SID
$1.31B
| $22.9K | 0.01% |
+16,368
| New | +$25.3K |
|
439
MaxCyte
MXCT
$133M
| $22.5K | 0.01% |
+10,300
| New | +$24.9K |
|
440
GrafTech
EAF
$181M
| $21.2K | 0.01% |
+2,182
| New | +$19.3K |
|
441
Fossil Group
FOSL
$245M
| $19.9K | 0.01% |
+13,430
| New | +$16.9K |
|
442
Iovance Biotherapeutics
IOVA
$2.23B
| $19.5K | 0.01% |
+11,343
| New | +$28.2K |
|
443
Fortress Biotech
FBIO
$112M
| $18.9K | 0.01% |
+10,171
| New | +$17.6K |
|
444
Rackspace Technology
RXT
$1.05B
| $18.5K | 0.01% |
+14,420
| New | +$18.8K |
|
445
Neumora Therapeutics
NMRA
$298M
| $18.4K | 0.01% |
+25,063
| New | +$19K |
|
446
Kosmos Energy
KOS
$1.33B
| $17.8K | 0.01% |
+10,363
| New | +$18.8K |
|
447
Tilray
TLRY
$531M
| $17.5K | 0.01% |
+4,224
| New | +$19.2K |
|
448
TScan Therapeutics
TCRX
$59.8M
| $16.2K | 0.01% |
+11,181
| New | +$16.2K |
|
449
SmartRent
SMRT
$186M
| $16.2K | 0.01% |
+16,336
| New | +$14.6K |
|
450
Standard BioTools
LAB
$350M
| $15.5K | 0.01% |
+12,947
| New | +$14.4K |
|
Similar funds
NED
CFG
CFG
WCM
OWA
TFP
HIMS
AFS
R Squared's Q2 2025 Portfolio in Review
As of Q2 2025, R Squared held 577 positions worth $181M, up 94% from $93.6M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
R Squared deployed $79.7M of net new capital in Q2 2025, opening 288 new positions and adding to 108 existing holdings. Its largest new stake was McDonald's: 13,589 shares worth $3.97M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Frontier Communications, an estimated $1.86M trimmed.
- R Squared's largest Q2 2025 buy was McDonald's: 13,589 shares worth $3.97M.
- R Squared added most to Kellanova in Q2 2025, an estimated $3.22M increase.
- R Squared's biggest Q2 2025 reduction was Frontier Communications, cutting an estimated $1.86M.
- R Squared fully exited Hilton Worldwide in Q2 2025, selling an estimated $1.58M.
- R Squared's ten largest holdings make up 13% of its $181M portfolio in Q2 2025.
- R Squared opened 288 new positions and closed 119 in Q2 2025.
- R Squared's portfolio value rose 94% quarter-over-quarter to $181M.
Based on R Squared's 13F filing for Q2 2025, filed 31 Jul 2025.